AwardedAwarded 10 June 2026
Blood Group Genotyping for Sickle Cell and Thalassaemia
NHS England · NHS and health
In brief
NHS England awarded healthcare work to NHSBT on 10 June 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.
Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to commencing 25 June 2025 until 31 March 2026.
Who won
| Winner | Value | Dates |
|---|---|---|
| NHSBT | £140,671 | Awarded 15 May 2025 10 June 2026 to 11 June 2026 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Transparency notice · UK5, notice 080318-2025
- Contract award notice · UK6, notice 080350-2025
- Contract details notice · UK7, notice 054590-2026
- Contract termination notice · UK11, notice 054644-2026
About the buyer
Similar open tenders
All open healthcare tenders- £7mestimated
- £82kestimated
- Value not stated
- Value not stated
- Value not stated
From notice 080318-2025 on Find a Tender, first published 5 December 2025, last updated 10 June 2026. We last checked for changes on 28 September 2026.